Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Use of nonaspirin nonsteroidal anti-inflammatory drugs and risk of head and neck cancer: A nationwide case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Transcriptome-wide association study reveals candidate causal genes for lung cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Cervical cancer risk in women living with HIV across four continents: A multicohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Transcriptome-wide association study reveals candidate causal genes for lung cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Initial treatment and survival in 4163 Danish patients with pancreatic cancer: A nationwide unselected real-world register study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • O Obazee
  • L Archibugi
  • A Andriulli
  • P Soucek
  • E Małecka-Panas
  • A Ivanauskas
  • T Johnson
  • M Gazouli
  • T Pausch
  • R T Lawlor
  • G M Cavestro
  • A C Milanetto
  • M Di Leo
  • C Pasquali
  • P Hegyi
  • A Szentesi
  • C E Radu
  • C Gheorghe
  • G E Theodoropoulos
  • F Bergmann
  • H Brenner
  • L Vodickova
  • V Katzke
  • D Campa
  • O Strobel
  • J Kaiser
  • R Pezzilli
  • F Federici
  • B Mohelnikova-Duchonova
  • U Boggi
  • R Lemstrova
  • J S Johansen
  • S E Bojesen
  • I Chen
  • B V Jensen
  • G Capurso
  • V Pazienza
  • C Dervenis
  • C Sperti
  • A Mambrini
  • T Hackert
  • R Kaaks
  • D Basso
  • R Talar-Wojnarowska
  • E Maiello
  • J R Izbicki
  • K Cuk
  • K U Saum
  • M Cantore
  • J Kupcinskas
  • O Palmieri
  • G Delle Fave
  • S Landi
  • R Salvia
  • P Fogar
  • Y K Vashist
  • A Scarpa
  • P Vodicka
  • C Tjaden
  • E Iskierka-Jazdzewska
  • F Canzian
View graph of relations

Rare truncating BRCA2 K3326X (rs11571833) and pathogenic CHEK2 I157T (rs17879961) variants have previously been implicated in familial pancreatic ductal adenocarcinoma (PDAC), but not in sporadic cases. The effect of both mutations in important DNA repair genes on sporadic PDAC risk may shed light on the genetic architecture of this disease. Both mutations were genotyped in germline DNA from 2,935 sporadic PDAC cases and 5,626 control subjects within the PANcreatic Disease ReseArch (PANDoRA) consortium. Risk estimates were evaluated using multivariate unconditional logistic regression with adjustment for possible confounders such as sex, age and country of origin. Statistical analyses were two-sided with p values <0.05 considered significant. K3326X and I157T were associated with increased risk of developing sporadic PDAC (odds ratio (OR dom) = 1.78, 95% confidence interval (CI) = 1.26–2.52, p = 1.19 × 10 −3 and OR dom = 1.74, 95% CI = 1.15–2.63, p = 8.57 × 10 −3, respectively). Neither mutation was significantly associated with risk of developing early-onset PDAC. This retrospective study demonstrates novel risk estimates of K3326X and I157T in sporadic PDAC which suggest that upon validation and in combination with other established genetic and non-genetic risk factors, these mutations may be used to improve pancreatic cancer risk assessment in European populations. Identification of carriers of these risk alleles as high-risk groups may also facilitate screening or prevention strategies for such individuals, regardless of family history.

Original languageEnglish
JournalInternational Journal of Cancer
Volume145
Issue number3
Pages (from-to)686-693
Number of pages8
ISSN0020-7136
DOIs
Publication statusPublished - 1 Aug 2019

    Research areas

  • Aged, BRCA2 Protein/genetics, Carcinoma, Pancreatic Ductal/genetics, Case-Control Studies, Checkpoint Kinase 2/genetics, Female, Genes, BRCA2, Genetic Predisposition to Disease, Germ-Line Mutation, Humans, Male, Middle Aged, Pancreatic Neoplasms/genetics, Polymorphism, Single Nucleotide

ID: 56638170